Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study
NCT03244241
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Insulin Degludec 100 UNT/ML [Tresiba]
Sponsor
Merete Bechmann Christensen
Collaborators
[object Object]